...
search icon
  • Apple, Inc AAPL
  • S&P 500 ETF Trust SPDR SPY
  • Alphabet Inc. - Class A Shares GOOGL
  • Microsoft Corporation MSFT
  • Meta Platforms Inc META
  • Netflix, Inc. NFLX
  • Amazon.com Inc. AMZN
  • Spotify Technology SA SPOT
    orka-img

    Oruka Therapeutics, Inc., Common Stock

    ORKA

    NMQ

    $10.62

    +$0.31

    (3.01%)

    1D
    Industry: Biotechnology Sector: Health Care

    Analyst Forecast

    Overview Returns Financials Ratios News FAQs

    Price Chart

    Key Metrics

    Market Cap info-icon
    This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
     $360.18M
    P/E Ratio info-icon
    This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
     0
    Volume info-icon
    This is the total number of shares traded during the most recent trading day.
     119.61K
    Avg Volume info-icon
    This is the average number of shares traded during the most recent 30 days.
     0
    Dividend Yield info-icon
    This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
     0.00%
    Beta info-icon
    This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
     0
    52-week Range info-icon
    This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
    $5.49 L
    $33 H
    $10.62

    About Oruka Therapeutics, Inc., Common Stock

    Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications. Its lead products include ORKA-001 that targets p19 subunit of interleukin-23, which is in phase 1 trial for the treatment of PsO; and ORKA-002 that targets interleukin-17A and interleukin-17F for the treatment of PsO, psoriatic arthritis, and other conditions. The company also develops ORKA-003 for targeting an undisclosed pathway; and ORKA-021, a sequential combination regimen of ORKA-002 and ORKA-001. Oruka Therapeutics, Inc. is headquartered in Menlo Park, California. more

    Industry: BiotechnologySector: Health Care

    Returns

    Time FrameORKASectorS&P500
    1-Week Return10.4%1.9%1.37%
    1-Month Return14.19%1.36%15.76%
    3-Month Return-5.85%-8.73%-2.58%
    6-Month Return-52.16%-5.96%0.72%
    1-Year Return-72.85%-7.97%12.24%
    3-Year Return-61.85%3.54%52.73%
    5-Year Return-76.59%34.17%100.37%
    10-Year Return-99.13%78.8%180.28%

    Ratios

    Asset Efficiency

    These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

    ORKA
    ROA (LTM) 0.00%
    ROE (LTM) 0.00%

    Valuation

    These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

    ORKA
    Trailing PE NM
    Forward PE NM
    P/S (TTM) 0.00
    P/B 0.00
    EV/R 0.00
    EV/Ebitda NM

    Discover more

    Tsla

    Tesla, Inc.
    aaple

    Apple, Inc.
    GOOGL

    Alphabet Inc. - Class A Shares
    META

    Meta Platforms Inc
    AMZN

    Amazon.com Inc.
    Microsoft

    Microsoft Corporation
    NVDA

    NVIDIA Corporation
    BRK

    Berkshire Hathaway Inc. Hld B
    LLY

    Eli Lilly and Company

    FAQs

    What is Oruka Therapeutics, Inc. share price today?

    Oruka Therapeutics, Inc. (ORKA) share price today is $10.62

    Can Indians buy Oruka Therapeutics, Inc. shares?

    Yes, Indians can buy shares of Oruka Therapeutics, Inc. (ORKA) on Vested. To buy Oruka Therapeutics, Inc. from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in ORKA stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

    Can Fractional shares of Oruka Therapeutics, Inc. be purchased?

    Yes, you can purchase fractional shares of Oruka Therapeutics, Inc. (ORKA) via the Vested app. You can start investing in Oruka Therapeutics, Inc. (ORKA) with a minimum investment of $1.

    How to invest in Oruka Therapeutics, Inc. shares from India?

    You can invest in shares of Oruka Therapeutics, Inc. (ORKA) via Vested in three simple steps:

    • Click on Sign Up or Invest in ORKA stock at the top of this page
    • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
    • Transfer USD funds to your US Brokerage account and start investing in Oruka Therapeutics, Inc. shares
    What is Oruka Therapeutics, Inc. 52-week high and low stock price?

    The 52-week high price of Oruka Therapeutics, Inc. (ORKA) is $33. The 52-week low price of Oruka Therapeutics, Inc. (ORKA) is $5.49.

    What is Oruka Therapeutics, Inc. price-to-book (P/B) ratio?

    The price-to-book (P/B) ratio of Oruka Therapeutics, Inc. (ORKA) is 0.00

    What is the Market Cap of Oruka Therapeutics, Inc.?

    The market capitalization of Oruka Therapeutics, Inc. (ORKA) is $360.18M

    What is Oruka Therapeutics, Inc.’s stock symbol?

    The stock symbol (or ticker) of Oruka Therapeutics, Inc. is ORKA

    Feedback

    Signup to access all features and start your US investing journey!

    • Open your account in minutes
    • Take your portfolio global, starting at just $1
    Get started

    Add ticker to compare

    Scroll to Top